ACTB-1003

SynDRA canonical compound SYN1965657 — structure-anchored drug synonym record

Clinical phase	Phase 1
Primary target(s)	FGF2 \| KDR \| RPS6KA1 \| RPS6KB1 \| TEK
Mechanism of action	FGFR inhibitor \| VEGFR inhibitor

All known targets

RPS6KB1
FGF2
FGFR1
FGFR2
FGFR3
FGFR4
KDR
RPS6KA1
TEK

Mechanisms of action (all sources)

FGFR inhibitor
VEGFR inhibitor
FGFR3 INHIBITOR
FGFR2 INHIBITOR
RPS6KB1 INHIBITOR
FGFR4 INHIBITOR
FGFR1 INHIBITOR

Cross-references

PubChem CID: 23653175
TTD: D0R6OM

Synonyms

Multi-mode kinase inhibitor (oral, cancer), ACT Biotech
Multi-mode kinase inhibitor (oral, cancer), Bayer

Look up ACTB-1003 in the interactive SynDRA portal →